Animal Models to Study Cardiac Arrhythmias
- PMID: 35679367
- PMCID: PMC9202503
- DOI: 10.1161/CIRCRESAHA.122.320258
Animal Models to Study Cardiac Arrhythmias
Abstract
Cardiac arrhythmias are a significant cause of morbidity and mortality worldwide, accounting for 10% to 15% of all deaths. Although most arrhythmias are due to acquired heart disease, inherited channelopathies and cardiomyopathies disproportionately affect children and young adults. Arrhythmogenesis is complex, involving anatomic structure, ion channels and regulatory proteins, and the interplay between cells in the conduction system, cardiomyocytes, fibroblasts, and the immune system. Animal models of arrhythmia are powerful tools for studying not only molecular and cellular mechanism of arrhythmogenesis but also more complex mechanisms at the whole heart level, and for testing therapeutic interventions. This review summarizes basic and clinical arrhythmia mechanisms followed by an in-depth review of published animal models of genetic and acquired arrhythmia disorders.
Keywords: atrial fibrillation; cardiomyopathies; channelopathies; models, animals; morbidity.
Figures



Similar articles
-
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as Models for Cardiac Channelopathies: A Primer for Non-Electrophysiologists.Circ Res. 2018 Jul 6;123(2):224-243. doi: 10.1161/CIRCRESAHA.118.311209. Circ Res. 2018. PMID: 29976690 Free PMC article. Review.
-
Abnormalities in sodium current and calcium homoeostasis as drivers of arrhythmogenesis in hypertrophic cardiomyopathy.Cardiovasc Res. 2020 Jul 15;116(9):1585-1599. doi: 10.1093/cvr/cvaa124. Cardiovasc Res. 2020. PMID: 32365196 Review.
-
German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management.Clin Res Cardiol. 2019 Jun;108(6):577-599. doi: 10.1007/s00392-018-1377-1. Epub 2018 Oct 10. Clin Res Cardiol. 2019. PMID: 30306295 Review.
-
Myocardial deletion of transcription factor CHF1/Hey2 results in altered myocyte action potential and mild conduction system expansion but does not alter conduction system function or promote spontaneous arrhythmias.FASEB J. 2014 Jul;28(7):3007-15. doi: 10.1096/fj.14-251728. Epub 2014 Mar 31. FASEB J. 2014. PMID: 24687990 Free PMC article.
-
Experimental Modeling Supports a Role for MyBP-HL as a Novel Myofilament Component in Arrhythmia and Dilated Cardiomyopathy.Circulation. 2017 Oct 17;136(16):1477-1491. doi: 10.1161/CIRCULATIONAHA.117.028585. Epub 2017 Aug 4. Circulation. 2017. PMID: 28778945 Free PMC article.
Cited by
-
Marine-Derived Compounds Applied in Cardiovascular Diseases: Submerged Medicinal Industry.Mar Drugs. 2023 Mar 21;21(3):193. doi: 10.3390/md21030193. Mar Drugs. 2023. PMID: 36976242 Free PMC article. Review.
-
Advances in cardiac organoid research: implications for cardiovascular disease treatment.Cardiovasc Diabetol. 2025 Jan 18;24(1):25. doi: 10.1186/s12933-025-02598-8. Cardiovasc Diabetol. 2025. PMID: 39827092 Free PMC article. Review.
-
Artificial Intelligence in the Heart of Medicine: A Systematic Approach to Transforming Arrhythmia Care with Intelligent Systems.Curr Cardiol Rev. 2025;21(4):e1573403X334095. doi: 10.2174/011573403X334095241205041550. Curr Cardiol Rev. 2025. PMID: 39902537
-
Identification of the optimal reference genes for atrial fibrillation model established by iPSC-derived atrial myocytes.BMC Genomics. 2024 Oct 25;25(1):1001. doi: 10.1186/s12864-024-10922-x. BMC Genomics. 2024. PMID: 39455925 Free PMC article.
-
RNA modification in cardiovascular disease: implications for therapeutic interventions.Signal Transduct Target Ther. 2023 Oct 27;8(1):412. doi: 10.1038/s41392-023-01638-7. Signal Transduct Target Ther. 2023. PMID: 37884527 Free PMC article. Review.
References
-
- Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991;324:781–8. - PubMed
-
- Cardiac Arrhythmia Suppression Trial III. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med. 1992;327:227–33. - PubMed
-
- Delisle BP, Anson BD, Rajamani S and January CT. Biology of cardiac arrhythmias: ion channel protein trafficking. Circ Res. 2004;94:1418–28. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical